MAMC Pharmacy Series: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) for the Pharmacist

This home study will address identification of at-risk patients with MASLD and discuss emerging therapeutic landscape for management.

Before you begin, you must view the presentation recording.

For more information about this activity, please contact Dr. Emily Leaf at [email protected].

Target Audience

This activity provides continuing education for pharmacists and pharmacy technicians across the Military Health System (MHS). A certificate of attendance is available for other attendees.

Learning Objectives

  1. Define Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and explain the rationale for the recent change in nomenclature.
  2. Describe the primary health risks associated with MASLD, including its impact on cardiovascular health, metabolic syndrome, and cancer risk.
  3. Identify the appropriate patient populations for MASLD screening and utilize non-invasive tests like the FIB-4 index to risk-stratify patients for advanced fibrosis.
  4. Explain the foundational role of lifestyle modifications, specifically the degree of weight loss required to improve steatosis, inflammation, and fibrosis.
  5. Compare the mechanisms of action, indications, and clinical benefits of newly approved pharmacotherapies for MASH, including resmetirom and semaglutide.
  6. Discuss the emerging therapeutic landscape for MASH and the potential role of next-generation agents in managing the disease.
Course summary
Available credit: 
  • 1.00 ACPE-Pharm

    UAN: JA4008136-0000-26-093-H01-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 ACPE-Tech

    UAN: JA4008136-0000-26-093-H01-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Attendance
Course opens: 
06/12/2026
Course expires: 
12/12/2026

Emily Leaf, PharmD, BC-ADM. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.

Terri Foster, PharmD, MA, CDCES. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.

Disclosure: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.

Available Credit

  • 1.00 ACPE-Pharm

    UAN: JA4008136-0000-26-093-H01-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 ACPE-Tech

    UAN: JA4008136-0000-26-093-H01-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Attendance
Please login or create an account to take this course.

Requirements:  CE/CME certificates are awarded to MHS participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest with a minimum score of 80% unless noted otherwise. The deadline to claim credit is Dec 12, 2026.

Access Code/Accommodations: Some activities require an access code to register or claim CE/CME credit. For inquiries regarding the access code or accommodations, please email Dr. Emily Leaf at [email protected]. 

For technical support, email [email protected].

Required Hardware/software